389 related articles for article (PubMed ID: 22405502)
21. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.
Amiri A; Sanchez-Ortiz E; Cho W; Birnbaum SG; Xu J; McKay RM; Parada LF
Autism Res; 2014 Feb; 7(1):60-71. PubMed ID: 24408886
[TBL] [Abstract][Full Text] [Related]
22. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
23. A single early-life seizure results in long-term behavioral changes in the adult Fmr1 knockout mouse.
Hodges SL; Reynolds CD; Nolan SO; Huebschman JL; Okoh JT; Binder MS; Lugo JN
Epilepsy Res; 2019 Nov; 157():106193. PubMed ID: 31520894
[TBL] [Abstract][Full Text] [Related]
24. Group I mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome.
Xu ZH; Yang Q; Feng B; Liu SB; Zhang N; Xing JH; Li XQ; Wu YM; Gao GD; Zhao MG
Mol Neurodegener; 2012 May; 7():24. PubMed ID: 22640474
[TBL] [Abstract][Full Text] [Related]
25. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
[TBL] [Abstract][Full Text] [Related]
26. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Henderson C; Wijetunge L; Kinoshita MN; Shumway M; Hammond RS; Postma FR; Brynczka C; Rush R; Thomas A; Paylor R; Warren ST; Vanderklish PW; Kind PC; Carpenter RL; Bear MF; Healy AM
Sci Transl Med; 2012 Sep; 4(152):152ra128. PubMed ID: 22993295
[TBL] [Abstract][Full Text] [Related]
27. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
[TBL] [Abstract][Full Text] [Related]
28. R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.
Qin M; Huang T; Kader M; Krych L; Xia Z; Burlin T; Zeidler Z; Zhao T; Smith CB
Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25820841
[TBL] [Abstract][Full Text] [Related]
29. Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice.
Gholizadeh S; Arsenault J; Xuan IC; Pacey LK; Hampson DR
Neuropsychopharmacology; 2014 Dec; 39(13):3100-11. PubMed ID: 24998620
[TBL] [Abstract][Full Text] [Related]
30. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
[TBL] [Abstract][Full Text] [Related]
31. Audiogenic Seizures in the
Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
[TBL] [Abstract][Full Text] [Related]
32. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
Dansie LE; Phommahaxay K; Okusanya AG; Uwadia J; Huang M; Rotschafer SE; Razak KA; Ethell DW; Ethell IM
Neuroscience; 2013 Aug; 246():186-98. PubMed ID: 23660195
[TBL] [Abstract][Full Text] [Related]
33. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
34. Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome.
Padmashri R; Reiner BC; Suresh A; Spartz E; Dunaevsky A
J Neurosci; 2013 Dec; 33(50):19715-23. PubMed ID: 24336735
[TBL] [Abstract][Full Text] [Related]
35. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
[TBL] [Abstract][Full Text] [Related]
36. The small GTPase Arf6 is dysregulated in a mouse model for fragile X syndrome.
Briševac D; Scholz R; Du D; Elagabani MN; Köhr G; Kornau HC
J Neurochem; 2021 May; 157(3):666-683. PubMed ID: 33125726
[TBL] [Abstract][Full Text] [Related]
37. Impaired presynaptic long-term potentiation in the anterior cingulate cortex of Fmr1 knock-out mice.
Koga K; Liu MG; Qiu S; Song Q; O'Den G; Chen T; Zhuo M
J Neurosci; 2015 Feb; 35(5):2033-43. PubMed ID: 25653361
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
39. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.
Pacey LK; Doss L; Cifelli C; van der Kooy D; Heximer SP; Hampson DR
Mol Cell Neurosci; 2011 Mar; 46(3):563-72. PubMed ID: 21215802
[TBL] [Abstract][Full Text] [Related]
40. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
